ReviewFrontiers in cell and developmental biology2026
Metastasis in biological time.
Review in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metastasis is the leading cause of cancer-related death, yet it is still interpreted largely through genetic, spatial, and microenvironmental models that treat the host as temporally uniform. Emerging evidence challenges this view by showing that metastatic progression unfolds within a hierarchically organized circadian system in which tumour cells, vascular interfaces, immune compartments, and distant organs operate in biological time. In this review, we examine how circadian regulation shapes multiple stages of the metastatic cascade, including tumour metastatic competence, circulating tumour cell release, vascular trafficking, immune-mediated seeding, niche permissiveness, colonization, and metastatic outgrowth. We discuss how tumour-intrinsic clocks influence invasive and secretory programmes, how endothelial and stromal rhythms create time-dependent windows of tissue access, and how circadian immune dynamics determine whether disseminated tumour cells are eliminated or licensed for persistence. We further highlight the role of systemic zeitgebers, including light-dark cycles, feeding-fasting rhythms, glucocorticoids, autonomic signalling, and body temperature, in coordinating or disrupting temporal alignment across metastatic compartments. Together, these observations support a conceptual shift: metastasis should be understood not only as a disease of space and state, but also as a disease of biological time. This framework may help explain metastatic heterogeneity and inform future precision oncology strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.